[Diagnostic and therapeutic potential of transesophageal cardiac pacing in the management of patients with arrhythmias].
Transoesophageal cardiostimulation is a semiinvasive method of stimulation of atrii enabling the performance of the programmed atrial stimulation without the inevitability of an invasive vascular approach. This method was used in 124 patients with the following indication spectrum. Diagnostic indications: total 82%, paroxysmal supraventricular tachycardia (SVT), and WPW sy-22%, tachycardia with wide QRS-complex-8%. SSS syndrome and bradycardia-20%, sycopes and collapses with unclear etiology-13%, palpitations-11%, control of antiarrhythmic therapy-4%, and other states-6%. Therapeutic indications: total-18%, versions of paroxysmal SVT and flutter of atrii. The patients with SVT were assumed to develop the arrhythmogenic mechanism--AV nodal re-entry tachycardia in 80%, orthodrome AV-re-entry tachycardia in 30%, and flutter of atrii in 20%. All patients with WPW-syndrome were stratified by the use of this method. The origin of this state from ventricular arrhythmia was verified in 40% of patients with tachycardia with a wide QRS complex. In coincidence with other indications, the diagnostic benefit of transoesophageal cardiostimulation was evaluated as follows: syncopes-68%, palpitations-64%, syndrome SSS and bradycardia-48%. The therapeutic indication of SVT version and flutter of atrii, was totally successful in 40%, partly successful in 45% and unsuccessful in 15% of patients. Transoesophageal cardiostimulation has contributed to the assessment of the diagnosis in 69% of patients and has acutely managed arrhythmia in 85% of cases. According to our experience, this method is effective in the initial management of patients with arrhythmia. Its low technical and economic demands make its wider utilisation appropriate in clinical practice of internal medicine. (Tab. 4, Fig. 9, Ref. 22).